GMP refers to the Good Manufacturing Practice regulations promulgated by the US Food and Drug Administration under the authority of the Federal Food, Drug, and Cosmetic Act (See Chapter IV for food, and Chapter V, Subchapters A, B, C, D, and E for drugs and devices.) These regulations, which have the force of law, require that manufacturers, processors, and packagers of drugs, medical devices, some food, and blood take proactive steps to ensure that their products are safe, pure, and effective.
GMP regulations require a quality approach to manufacturing, enabling companies to minimize or eliminate instances of contamination, mixups, and errors. This protects the consumer from purchasing a product which is not effective or even dangerous. Failure of firms to comply with GMP regulations can result in very serious consequences including recall, seizure, fines, and jail time.
GMP regulations address issues including record keeping, personnel qualifications, sanitation, cleanliness, equipment verification, process validation, and complaint handling. Most GMP requirements are very general and open-ended, allowing each manufacturer to decide individually how to best implement the necessary controls. This provides much flexibility, but also requires that the manufacturer interpret the requirements in a manner which makes sense for each individual business.
GMP is also sometimes referred to as "cGMP". The "c" stands for "current," reminding manufacturers that they must employ technologies and systems which are up-to-date in order to comply with the regulation. Systems and equipment used to prevent contamination, mixups, and errors, which may have been first-rate 20 years ago may be less than adequate by current standards.
View Other ResourcesPharmaceutical Engineering Magazine Articles
Evolving China’s Regulatory System in Alignment with ICH
With the Chinese government initiating drug regulatory reform in 2015 and China joining the…
Navigating the Asia Pacific Pharmaceutical Landscape for Global Impact
The Asia Pacific region (APAC), like any large territory, encompasses a blend of well-established…
Live Biotherapeutic Products: Moving the Microbiome to the Patient
Live biotherapeutic products (LBPs) have the potential to treat a wide range of ailments. However…
CMC Requirements for New Drug Registration in Latin America
The global pandemic has demonstrated that now, more than ever, we need to work toward a global…
Enabling More Efficient and Effective C&Q Through GEP
When the ISPE Baseline Guide Vol. 5, Commissioning & Qualification, 2 ed . was published in 2019…
AI Governance and QA Framework: AI Governance Process Design
Artificial intelligence (AI) has the potential to benefit the pharmaceutical industry and its GxP…
Software as a Service: The Journey to Becoming a Life Sciences SAAS Provider
Use of software as a service (SaaS) applications within the life sciences industry is growing. This…
ISPE Briefs: New Edition of Good Practice Guide on Maintenance Is Available
Maintenance can impact both the quality of products and the compliance of pharmaceutical processes…
A Beginner’s Guide to IT System Inspection Readiness
This article provides a beginner’s overview of how organizations can achieve a state of preparedness…
Industry 4.0 & the Future of the Pharmaceutical Industry
Industry 4.0 is the recent movement toward intelligent automation technology. In this new era, the…
Breaking with Tradition: Laying the Foundation for Validation 4.0
A fundamental GMP requirement is that processes, systems, and methods used to produce medicines and…
GMP Implementation of Online Water Bioburden Analyzers
Online water bioburden analyzers (OWBAs) are analytical instruments providing real-time or near real…
Related Guidance Documents
Active Pharmaceutical Ingredients (1)
Compounding (1)
Good Manufacturing Practice (2)
Quality Assurance (1)
Regulatory (1)
Community Discussions
Community Discussions
Nov 20, 2024
Regulatory
Regulatory
Nov 18, 2024
Regulatory
Regulatory
Nov 17, 2024
Sustainable Facilities, HVAC, & Controlled Environments
Manufacturing Operations
Nov 17, 2024
Nov 04, 2024
Information Systems
Management
Pharma 4.0™
Project Management
Nov 04, 2024
Regulatory
Supply Chain
Active Pharmaceutical Ingredients
Good Manufacturing Practice
Nov 03, 2024
Women in Pharma®
Webinars Related to GMPs
Concept and Discussion Papers
GMP Regulation Handbook: General, Finished Pharmaceuticals, 21 CFR Parts 210 & 211
Regulation Handbook: 21 CFR Parts 210 (General) & 211 (Finished Pharmaceuticals) Current Good…
GMP Regulation Handbook: Medical Devices, 21 CFR Part 820
Regulation Handbook: 21 CFR Part 820: Medical Devices Quality Systems Regulation (formerly known as…
GMP Regulation Handbook: Electronic Signatures, 21 CFR Part 11
The 21 CFR Part 11 regulation handbook is used in association with ISPE training courses. Attendees…
GMP Regulation Handbook: Dietary Supplements, 21 CFR Part 111
GMP Regulation Handbook 21 CFR Part 111 Code of Federal Regulations US Food and Drug Administration…
GMP Regulation Handbook: Active Pharmaceutical Ingredients, ICH Q7
This GMP Regulation Handbook represents the FDA's current thinking regarding GMPs for manufacturing…
iSpeak Blog Posts Related to GMPs
Featured Conferences
Training Programs Related To [Category]
GxPs for Leadership
This comprehensive course will equip you with the knowledge and skills to ensure GxP compliance and inspection readiness in the pharmaceutical industry. You will thoroughly understand regulatory requirements and learn about management's role in maintaining safety and quality. The course covers essential topics such as regulatory expectations, responsibilities in compliance, and consequences of non-compliance.
GMP Refresher
Code of Federal Regulations (CFR) states that "Training in current good manufacturing practice shall be conducted by qualified individuals on a continuing basis and with sufficient frequency to assure that employees remain familiar with cGMP requirements applicable to them." This course will provide an overview of History, Regulations, Quality Systems, and development, with a focus on distinguishing between QA and QC in GMP. It can serve as a GMP refresher for both individuals and companies and ensures that current key trends are covered. CEUs are provided once you achieve an 80% passing grade…
GMP Fundamentals: Eleven-Part Bundle Series
Obtain a 10% Savings by Purchasing All Eleven Courses Overview ISPE is presenting an eleven-part series that will focus on the fundamentals of good manufacturing practices (GMPs). The series provides an overview of the regulations pertaining to GMPs and covers topics such as: manufacturing controls, product distribution, plant hygiene, documentation practices, buildings & facilities, organizational structure, and more. This offering gives users access to all eleven modules of the series and is intended to introduce GMPs for the new pharmaceutical employee or to provide an annual refresher for…
CAPA / RCA / Investigations Training Course
Coming Soon 2024 - CAPA and Continuous Improvement using Process Performance & Product Quality Monitoring (PPPQMS), are elements of the Pharmaceutical Quality System (PQS), supported by ICH Q10. By practicing effective CAPA and PPPQMS a Pharmaceutical Quality System can realize Quality Management Maturity.
GMP Fundamentals: Holding & Distribution
In this course, you will learn the requirements for storing, handling, and distributing finished products to ensure they are stored properly and not contaminated or altered during transport. For a limited time, registration fees are waived for this course. Interactive Course: What to Expect CEUs are provided once you achieve an 80% passing grade and complete the evaluation. Buy Now Return to Online Learning